TRAVAGLINI, SERENA
TRAVAGLINI, SERENA
Dipartimento di Medicina Sperimentale
A minimal promoter region of Kit gene recapitulates mast cell differentiation in development, aging and inflammation
2023-06-01 Fuda, S; Angelini, D; Colopi, A; Guida, E; Onorato, A; Grimaldi, P; Travaglini, S; Jannini, E; Dolci, S
Advances in the pathogenesis of FLT3 -mutated acute myeloid leukemia and targeted treatments
2024-01-01 Travaglini, S; Gurnari, C; Ottone, T; Voso, Mt
AI-driven transcriptomic encoders: from explainable models to accurate, sample-independent cancer diagnostics
2024-01-01 Croce, D; Smirnov, A; Tiburzi, L; Travaglini, S; Costa, R; Calabrese, A; Basili, R; LEVIALDI GHIRON, N; Melino, G
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting
2023-06-16 Attardi, E; Savi, A; Borsellino, B; Piciocchi, A; Cipriani, M; Ottone, T; Fabiani, E; Divona, M; Travaglini, S; Pascale, Mr; Awada, H; Durmaz, A; Visconte, V; Della Porta, Mg; Venditti, A; Maciejewski, Jp; Gurnari, C; Voso, Mtt
Characterization of a novel IDH2‐R159H mutation in acute myeloid leukaemia: Effects on cell metabolism and differentiation
2023-01-01 Nardozza, Am; Guarnera, L; Travaglini, S; Ottone, T; Divona, M; De , E; Bellis, ; Savi, A; Banella, C; Noguera, Ni; Di , D; Fusco, ; Monteleone, I; Voso, Mt
Combination treatment of resistant acute promyelocytic leukemia cells with arsenic trioxide and anti-apoptotic gene inhibitors
2024-11-14 Giansanti, M; Ottone, T; Travaglini, S; Voso, Mt; Graziani, G; Faraoni, I
Evolution of transcriptomic profiles in relapsed inv(16) acute myeloid leukemia
2024-10-01 Travaglini, S; Silvestrini, G; Attardi, E; Fanciulli, M; Scalera, S; Antonelli, S; Maurillo, L; Palmieri, R; Divona, M; Ciuffreda, L; Savi, A; Paterno, G; Ottone, T; Barbieri, C; Maciejewski, J; Gurnari, C; Ciliberto, G; Voso, M
Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways
2023-10-06 Ottone, T; Silvestrini, G; Piazza, R; Travaglini, S; Gurnari, C; Marchesi, F; Nardozza, Am; Fabiani, E; Attardi, E; Guarnera, L; Divona, M; Ricci, P; Irno Consalvo, Ma; Ienzi, S; Arcese, R; Biagi, A; Fiori, L; Novello, M; Mauriello, A; Venditti, A; Anemona, L; Voso, Mt
Functional characterization and response to FLT3 inhibitors in acute myeloid leukaemia with a non-canonical FLT3 mutation: A proof of concept
2023-07-01 Travaglini, S; Gurnari, C; Antonelli, S; Marchesi, F; De , ; Angelis, G; Ottone, T; Divona, M; Cristiano, A; Hajrullaj, H; Mengarelli, A; Voso, Mt
PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias
2025-09-10 Zaza, A; Zardo, G; Banella, C; Tucci, S; De Marinis, E; Gentile, M; Travaglini, S; Divona, M; Ottone, T; Castelli, G; Cerio, Am; Angelini, Df; Faraoni, I; Palmieri, R; Niscola, P; Ammatuna, E; Venditti, A; Nervi, C; Voso, Mt; Catalano, G; Noguera, Ni
Retinoic acid and proteotoxic stress induce AML cell death overcoming stromal cell protection
2023-01-01 Liccardo, F; Sniegocka, M; Tito, C; Iaiza, A; Ottone, T; Divona, M; Travaglini, S; Mattei, M; Cicconi, R; Miglietta, S; Familiari, G; Nottola, Sa; Petrozza, V; Tamagnone, L; Voso, Mt; Masciarelli, S; Fazi, F
YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells
2023-01-01 Noguera, N; Travaglini, S; Scalea, S; Catalanotto, C; Reale, A; Zampieri, M; Zaza, A; Rosaria RICCIARDI, M; Angelini, Df; Tafuri, A; Ottone, T; Voso, Mt; Zardo, G
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-giu-2023 | A minimal promoter region of Kit gene recapitulates mast cell differentiation in development, aging and inflammation | Fuda, S; Angelini, D; Colopi, A; Guida, E; Onorato, A; Grimaldi, P; Travaglini, S; Jannini, E; Dolci, S | Articolo su rivista | |
| 1-gen-2024 | Advances in the pathogenesis of FLT3 -mutated acute myeloid leukemia and targeted treatments | Travaglini, S; Gurnari, C; Ottone, T; Voso, Mt | Articolo su rivista | |
| 1-gen-2024 | AI-driven transcriptomic encoders: from explainable models to accurate, sample-independent cancer diagnostics | Croce, D; Smirnov, A; Tiburzi, L; Travaglini, S; Costa, R; Calabrese, A; Basili, R; LEVIALDI GHIRON, N; Melino, G | Articolo su rivista | |
| 16-giu-2023 | Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting | Attardi, E; Savi, A; Borsellino, B; Piciocchi, A; Cipriani, M; Ottone, T; Fabiani, E; Divona, M; Travaglini, S; Pascale, Mr; Awada, H; Durmaz, A; Visconte, V; Della Porta, Mg; Venditti, A; Maciejewski, Jp; Gurnari, C; Voso, Mtt | Articolo su rivista | |
| 1-gen-2023 | Characterization of a novel IDH2‐R159H mutation in acute myeloid leukaemia: Effects on cell metabolism and differentiation | Nardozza, Am; Guarnera, L; Travaglini, S; Ottone, T; Divona, M; De , E; Bellis, ; Savi, A; Banella, C; Noguera, Ni; Di , D; Fusco, ; Monteleone, I; Voso, Mt | Articolo su rivista | |
| 14-nov-2024 | Combination treatment of resistant acute promyelocytic leukemia cells with arsenic trioxide and anti-apoptotic gene inhibitors | Giansanti, M; Ottone, T; Travaglini, S; Voso, Mt; Graziani, G; Faraoni, I | Articolo su rivista | |
| 1-ott-2024 | Evolution of transcriptomic profiles in relapsed inv(16) acute myeloid leukemia | Travaglini, S; Silvestrini, G; Attardi, E; Fanciulli, M; Scalera, S; Antonelli, S; Maurillo, L; Palmieri, R; Divona, M; Ciuffreda, L; Savi, A; Paterno, G; Ottone, T; Barbieri, C; Maciejewski, J; Gurnari, C; Ciliberto, G; Voso, M | Articolo su rivista | |
| 6-ott-2023 | Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways | Ottone, T; Silvestrini, G; Piazza, R; Travaglini, S; Gurnari, C; Marchesi, F; Nardozza, Am; Fabiani, E; Attardi, E; Guarnera, L; Divona, M; Ricci, P; Irno Consalvo, Ma; Ienzi, S; Arcese, R; Biagi, A; Fiori, L; Novello, M; Mauriello, A; Venditti, A; Anemona, L; Voso, Mt | Articolo su rivista | |
| 1-lug-2023 | Functional characterization and response to FLT3 inhibitors in acute myeloid leukaemia with a non-canonical FLT3 mutation: A proof of concept | Travaglini, S; Gurnari, C; Antonelli, S; Marchesi, F; De , ; Angelis, G; Ottone, T; Divona, M; Cristiano, A; Hajrullaj, H; Mengarelli, A; Voso, Mt | Articolo su rivista | |
| 10-set-2025 | PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias | Zaza, A; Zardo, G; Banella, C; Tucci, S; De Marinis, E; Gentile, M; Travaglini, S; Divona, M; Ottone, T; Castelli, G; Cerio, Am; Angelini, Df; Faraoni, I; Palmieri, R; Niscola, P; Ammatuna, E; Venditti, A; Nervi, C; Voso, Mt; Catalano, G; Noguera, Ni | Articolo su rivista | |
| 1-gen-2023 | Retinoic acid and proteotoxic stress induce AML cell death overcoming stromal cell protection | Liccardo, F; Sniegocka, M; Tito, C; Iaiza, A; Ottone, T; Divona, M; Travaglini, S; Mattei, M; Cicconi, R; Miglietta, S; Familiari, G; Nottola, Sa; Petrozza, V; Tamagnone, L; Voso, Mt; Masciarelli, S; Fazi, F | Articolo su rivista | |
| 1-gen-2023 | YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells | Noguera, N; Travaglini, S; Scalea, S; Catalanotto, C; Reale, A; Zampieri, M; Zaza, A; Rosaria RICCIARDI, M; Angelini, Df; Tafuri, A; Ottone, T; Voso, Mt; Zardo, G | Articolo su rivista |